May 18, 2023 01:40 PM EDTUpdated May 19, 05:52 PM

AbbVie tackles ‘gutsy’ conversation in social media series for IBD sufferers

Beth Snyder Bulik

Senior Editor

AbbVie wants to remind people about the importance of honest discussions in inflammatory bowel disease (IBD) with the kickoff of a new YouTube conversation series …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AbbVie tackles ‘gutsy’ conversation in social media series for IBD sufferers

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Ab­b­Vie tack­les ‘gut­sy’ con­ver­sa­tion in so­cial me­dia se­ries for IBD suf­fer­ers

Senior Editor

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

AbbVie tackles ‘gutsy’ conversation in social media series for IBD sufferers